Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Nab-paclitaxel and Cisplatin in Muscle-Invasive Bladder Cancer
NCT04060459Phase 2Unknown
- Sponsor
- Army Medical University
- Start
- Oct 2018
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel in muscle-invasive bladder cancer (MIBC), sponsored by Army Medical University. Status: unknown.
02
Drugs
paclitaxel
03
Conditions
muscle-invasive bladder cancer (MIBC)
Beyond the preview
Go deeper on NCT04060459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04060459.